The so-called lymphoma, which are cancers of the immune system, originate in white blood cells. Pathological B cells, for instance, are responsible for the "diffuse large B cell lymphoma", which progress very aggressively if left untreated.
In Germany, about 3,000 people are affected by this disease each year. Usually, the patients complain of fever, night sweats and weight loss. Furthermore, they are often pale and tired and exhibit swollen lymph nodes.
25 percent of the patients die
"With a combination treatment of immunotherapy and chemotherapy, this kind of lymphoma can be kept under long-term control or even be cured in about 75 percent of the cases," says Professor Andreas Rosenwald, who works as a pathologist at the University of Würzburg. Why about 25 percent of the patients die from this cancer is still not completely understood at present.
Chronically stimulated protein detected
In recent years, an international research consortium, including Rosenwald's team, has defined two main biologically and clinically distinguishable subgroups of the diffuse large B cell lymphoma.
Now, the researchers have established: In one of these subgroups, a B-cell-specific protein, the so-called B cell receptor, is chronically stimulated. Obviously, this is conducive to the growth of the tumor. "The biological mechanism leading to the continuous stimulation of the receptor was unknown till now. It has been described for the first time in our publication in Nature," explains Rosenwald.
Possible approach for a new therapy
This new finding might be used for future therapy. For instance, it is conceivable that some medication with so-called kinase blockers could be used to curb the out-of-control stimulation. However, this possibility must first be tested in clinical trials over the coming years.
A further assumption must also be examined: There are indications that the chronically stimulated B cell receptor may be responsible for at least some of the cases in which the lymphoma patients die despite receiving treatment.
Eight partners in the consortium
The international consortium that has launched this publication in Nature consists of eight institutions from the USA, Germany, Canada, Norway and Spain. The German contributors to the research are the Würzburg professors Andreas Rosenwald, Hans Konrad Müller-Hermelink and German Ott. Professor Rosenwald has been the director of the Institute of Pathology at the University of Würzburg since September 2009.
Publications in highly regarded journals
"The partners in the consortium have been working closely together since 2000 and this collaboration has proven to be very productive. So far, we have launched about 50 joint publications, several of them in highly regarded journals, such as Nature, Science and the New England Journal of Medicine," says Professor Rosenwald. The success of these studies can only be ascribed to the intensive international teamwork of molecular biologists, genome researchers, hematologists and pathologists - any individual institution would have been overwhelmed by the task.
With its internationally recognized interdisciplinary research projects spanning many years, the consortium has submitted an application for the Team Science Award, a renowned annual award established by the American Association for Cancer Research, which is worth 50,000 dollars in prize money. The scientists consider their chances of winning the award to be quite good.
Lymphoma - a Würzburg specialist field
For the current publication in Nature, Rosenwald's team participated in providing a more detailed pathological and genetic characterization of the respective lymphoma cells in the examined cases. Lymphoma are a specialist field of the Würzburg researchers; the Institute of Pathology at the University of Würzburg is one of six nationwide reference centers for lymph node pathology in Germany.
"Chronic Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma", R. Eric Davis, Vu N. Ngo, Georg Lenz, Pavel Tolar, Ryan Young, Paul B. Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang, Weihong Xu, Arthur L. Shaffer, George Wright, Wenming Xiao, John Powell, Jian-kang Jiang, Craig J. Thomas, Andreas Rosenwald, German Ott, Hans Konrad Muller-Hermelink, Randy D. Gascoyne, Joseph M. Connors, Lisa M. Rimsza, Elias Campo, Elaine S. Jaffe, Jan Delabie, Erlend B. Smeland, Richard I. Fisher, Rita M. Braziel, Raymond R. Tubbs, J. R. Cook, Denny D. Weisenburger, Wing C. Chan, Susan K. Pierce, and Louis M. Staudt. Nature 463, 7. Januar 2010, pp 88-92, doi:10.1038/nature08638
Prof. Dr. Andreas Rosenwald, Institute of Pathology, University of Würzburg, phone +49 931 201-47777, firstname.lastname@example.org
Robert Emmerich | idw
First time-lapse footage of cell activity during limb regeneration
25.10.2016 | eLife
Phenotype at the push of a button
25.10.2016 | Institut für Pflanzenbiochemie
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
25.10.2016 | Earth Sciences
25.10.2016 | Life Sciences
25.10.2016 | Earth Sciences